The U.S. has recently marked the one year anniversary of the official declaration of the COVID-19 pandemic by the World Health Organization. The pandemic thrust clinical research into the limelight like never before and – while daunting and challenging – the scientific community answered its collective call-to-duty with impressive vigor and determination. But our work continues and this anniversary provides an important opportunity for reflection, discussion and evaluation.
Many have pointed to a large number of initiated clinical trials as evidence of successful research in response to the global health crisis. However, the true measure of success should be in actionable and reliable research results that are available to inform clinical, policy and research decisions related to the diagnosis, treatment, and prevention of COVID-19 and its variants.
In this webinar, moderated by CTTI Acting Executive Director Leanne Madre, CTTI will present findings from an analysis of data downloaded from the database for the Aggregate Analysis of ClinicalTrials.gov (AACT) on the state of U.S. COVID-19 studies. Presenters will give an overview on the data analysis and discuss how the findings can be applied to improvements needed across the clinical trials ecosystem.
The presenters include:
• Robert Califf, Verily and Google Health
• Harlan Krumholz, Yale School of Medicine
• Deborah Zarin, Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard University
If you need a disability accommodation, please contact CTTI Events (email@example.com). Requests should be made by April 8, 2021.
We hope you can join us!